OFFICIAL NOTICE CONTENT
Opportunity description
The purpose of this requirement is for the acquisition of reagents and consumables required for the Early Detection of Lung Diseases (EDLI) project. These reagents are specifically designed and exclusively compatible with the 10X Genomics Chromium platform, a proprietary system that enables high-resolution gene expression analysis. The EDLI project relies on these reagents to ensure experimental continuity, data accuracy, and reproducibility in studies focused on identifying early biomarkers and understanding the mechanisms of infectious and noninfectious lung diseases. As sole-source items, these reagents cannot be substituted without disrupting ongoing experiments and compromising the integrity of the research. The acquisition will support the project�s critical mission to advance diagnostic and therapeutic approaches for lung diseases. � Product Service Code: 6640 � Laboratory Equipment and Supplies � NAICS Code: 325413 � In-Vitro Diagnostic Substance Manufacturing � Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA POTS: 26-009308 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested. The National Institutes of Health (NIH) intends to award a one-year contract to 10X Genomics, located at 6230 Stoneridge Mall Rd, Pleasanton, CA 94588-3260, on a firm fixed price sole source award basis for the acquisition of reagents and consumables required for the Early Detection of Lung Diseases project. The proposed vendor, 10X Genomics, is the sole source for the reagents required for use with the 10X Genomics instrument. Their proprietary reagents are uniquely designed and exclusively compatible with their instrument, ensuring optimal performance and data integrity. This kit is a specialized reagent set designed exclusively for the 10X Genomics Chromium platform/instrument, enabling cutting-edge single-cell and multiomic analyses. The GEM-X Universal 5' Gene Expression v3 Kit facilitates high-resolution gene expression profiling, immune repertoire analysis, and other advanced applications critical to identifying early biomarkers and understanding the molecular mechanisms of infectious and noninfectious lung diseases. These capabilities are essential to achieving the EDLI project�s objectives, which aim to advance diagnostic and therapeutic strategies for lung health. Due to the proprietary nature of the GEM-X Universal 5' Gene Expression v3 and its unique compatibility with the 10X Genomics system, no alternative supplies can meet the technical requirements of the EDLI project. Procuring this kit is essential for ensuring the continuity and success of the research. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to huda.malik@nih.gov by September 23, 2026 at 11 am EST.
FEDERAL BUYER
Buyer and contracting office
Public points of contact
GOVBIDFIT SCREENING LENS
What deserves attention before you spend bid time
These screening signals are generated from the public notice fields stored for this specific opportunity. They are not eligibility findings or predictions; they are prompts for a faster, more disciplined review of the official solicitation.
This is a pre-solicitation signal. Use it to prepare, verify likely eligibility and watch for the formal solicitation or amendments before committing proposal effort.
The stored deadline is within three days. Check earlier question, site-visit and attachment requirements immediately; the final response date may not be the first deadline that matters.
No Set aside used is recorded as the set-aside or restriction. Confirm the bidding entity actually satisfies the applicable program and size requirements before investing proposal time.
NAICS 325413 · PSC 6640 is the recorded classification. Use it as a screening clue, then compare the actual scope and deliverables rather than treating the code alone as proof of fit.
GovBidFit has stored substantive notice text for this record, but attachments, clauses, amendments and Q&A can still contain requirements that are not visible in the description alone.
The source data includes 1 public contracting contact. Use the solicitation's stated communication rules and deadlines before contacting the buyer.
Questions to resolve next
What this opportunity record tells you
SAM.gov identifies this as a presolicitation from HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The record was posted on September 18, 2026 and currently lists September 23, 2026 as the response deadline. GovBidFit keeps source facts separate from its matching guidance so you can see what comes from the federal notice.
The listed product or service classification is NAICS 325413 · PSC 6640. The set-aside field is No Set aside used. These fields help narrow your search, but they do not replace the full solicitation, amendments, attachments, clauses or eligibility language on the official source.
Before deciding to bid
GovBidFit is independent and is not a U.S. government website. GovBidFit stores a structured mirror of SAM.gov public opportunity data in its own database and keeps the compact snapshot as a fallback. The official SAM.gov notice remains the controlling source. The official SAM.gov notice controls if anything here differs from the source or a later amendment.
Open the official SAM.gov notice →